Identifying new markers for breast cancer prognosis
Identification de Nouveaux Marqueurs Pronostiques Des Cancers du Sein
This study is trying to find new genetic markers in breast cancer tumors to help predict how the disease will progress and improve treatment for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 1 site (Grenoble) |
| Trial ID | NCT03436069 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify and validate new prognostic markers for breast cancer using tumor samples from both retrospective and prospective cohorts. The research leverages an innovative approach developed by the team, which focuses on detecting ectopic gene expression through public pan-genomic breast cancer data. By correlating these genetic markers with clinical outcomes, the study seeks to improve the assessment of relapse and metastasis risks, ultimately enhancing treatment personalization and minimizing side effects for patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adult female patients diagnosed with breast cancer.
Not a fit: Patients with other active cancers or those unable to provide necessary information due to language barriers or recent relocation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate prognostic assessments for breast cancer patients, allowing for tailored treatment strategies.
How similar studies have performed: Previous studies have successfully utilized similar approaches in other cancers, indicating potential for success in this context as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult female patients with breast cancer Exclusion Criteria: * Presence of another cancer, excluding basal cell cancers or pre-neoplastic lesions of the cervix. * Subject under guardianship or subject deprived of liberty * Impossibility of collecting information on exposure (subjects recently arrived in France, foreign language, etc.) * Male patients
Where this trial is running
Grenoble
- Anne-Cécile PHILIPPE — Grenoble, France (Recruiting)
Study contacts
- Principal investigator: Anne-Cécile PHILIPPE, Dr — University Hospital, Grenoble
- Study coordinator: Anne-Cécile PHILIPPE, Dr
- Email: ACPhilippe@chu-grenoble.fr
- Phone: +33476766677
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.